Advertisement

Ultrastructural Correlates of Antimycotic Treatment

  • Marcel Borgers
Part of the Current Topics in Medical Mycology book series (CT MYCOLOGY, volume 2)

Abstract

The descriptive ultrastructure of a large variety of fungal species either grown under in vitro culture conditions or in situ during infection of the host has been reported in detail. Morphologic characterization of yeasts, dimorphic fungi, and filamentous fungi has been done using scanning electron microscopy to elaborate the surface structure, transmission electron microscopy to reveal the internal subcellular organelles, and freeze-fracture electron microscopy to display some intramembranous molecular structures (2, 3, 5, 6, 12, 17, 28, 31, 45, 50, 61, 64, 66, 70, 75, 83, 85, 112, 113, 124). For a long time the detailed description of fungal substructure has been hampered by the lack of adequate methodology. From the early days of explorative research, especially the field of transmission electron microscopy has been encumbered with difficulties of clear-cut visualization, hence obscuring the interpretation of the observations (17).

Keywords

Yeast Cell Candida Albicans Pityriasis Versicolor Trichophyton Mentagrophytes Azole Derivative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aerts F, Van Cutsem J, De Brabander M: The activity of ketoconazole and itraconazole against Aspergillusfumigatus in mixed cultures with macrophages or leukocytes. Mykosen 29:165–176, 1986.PubMedGoogle Scholar
  2. 2.
    Agar HD, Douglas HD: Studies on the cytological structure of yeast: Electron microscopy of thin section. J Bacterial 73:365–375, 1957.Google Scholar
  3. 3.
    Al-Doory Y : The ultrastructure of Cryptococcus neoformans. Sabouraudia 9:113–120, 1971.CrossRefGoogle Scholar
  4. 4.
    Arai T, Mikami Y, Yokoyama K, Kawata T, Masuda K: Morphological changes in yeasts as a result of the action of 5-fluorocytosine. Antimicrob Agents Chemother 12:255–260, 1977.PubMedGoogle Scholar
  5. 5.
    . Avers CJ, Federman M: The occurrence in yeast of cytoplasmic granules which resemble microbodies. J Cell Biol 37:555–560, 1968.PubMedCrossRefGoogle Scholar
  6. 6.
    Bakerspigel A : Some observations on the cytology of Candida albicans. J. Bacteriol 87:228–237, 1964.PubMedGoogle Scholar
  7. 7.
    Barug D, de Groot C : Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Arzneim Forsch Drug Res 33:538–545, 1983.Google Scholar
  8. 8.
    Barug D, Samson RA, Kerkenaar A: Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Arzneim Forsch Drug Res 33:528–537, 1983.Google Scholar
  9. 9.
    Bastide M. Jouvert S, Bastide JM : Action des antifongiques sur la paroi et la membrane cytoplasmique de Candida albicans revelee par microscopic electronique a balayage. I. Amphotericine B et nystatine. Bull Soc My col Med 10:113–118, 1981.Google Scholar
  10. 10.
    Bastide M, Jouvert S, Bastide JM: A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: An ultrastructural study by scanning electron microscopy. Can J Microbiol 28:1119–1126, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Bastide M, Jouvert S, Bastide JM: Etude cytologique de Faction des imidazoles sur Candida albicans. Pathol Biol 30:458–462, 1982.PubMedGoogle Scholar
  12. 12.
    Beckett A, Heath IB, McLaughlin DJ: An Atlas of Fungal Ultrastructure. London, Longman, 1972, pp 1–221.Google Scholar
  13. 13.
    Bent KJ, Moore RH: The mode of action of griseofulvin, in Biochemical Studies of Antimicrobial Drugs. 16th Symposium of Society of General Microbiology. London, Cambridge University Press, 1966, pp 82–110.Google Scholar
  14. 14.
    Blank H, Taplin D, Roth FJ: Electron microscopic observations of the effects of griseofulvin on dermatophytes. Arch Dermatol 81:667–680, 1960.PubMedGoogle Scholar
  15. 15.
    Borgers M: Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis 2:520-534, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Borgers M: Antifungal Azole Derivatives. Symposium of the Society for General Microbiology. Scientific Basis of Antimicrobial Chemotherapy, Greenwood D. O’Grady F (eds).London, Cambridge University Press, 1985, pp 133–153.Google Scholar
  17. 17.
    Borgers M, De Nollin S: The preservation of subcellular organelles of Candida albicans with conventional fixatives. J Cell Biol 62:574–581, 1974.PubMedCrossRefGoogle Scholar
  18. 18.
    Borgers M, Van Cutsem J: Ketoconazole induced morphological changes In yeasts and dermatophytes, In Meinhof W (ed): Oral Therapy in Dermatomycoses: A Step Forward. The Medicine Publishing Foundation, 1985, pp 51-60.Google Scholar
  19. 19.
    Borgers M, Vanden Bossche H: The mode of action of antifungal drugs, Levine HB : Ketoconazole in the Management of Fungal Disease. New York, Adis Press, 1982, pp 25–27.Google Scholar
  20. 20.
    Borgers M, Van de Ven M: Sensitivity testing and morphological changes in Candida albicans after ketoconazole treatment. The Cervix 2:149–158, 1984.Google Scholar
  21. 21.
    Borgers M, Van de Ven MA: Degenerative changes in fungi after itraconazole treatment. Rev Infect Dis, 9 (suppl. 1):S33–S42, 1987.CrossRefGoogle Scholar
  22. 22.
    Borgers M, De NollIn S, Verheyen A, De Brabander M, Thienpont D: Effects of new anthelmintics on the micro tubular system of parasites, In Borgers M and De Brabander M (eds): Microtubules and Microtubule Inhibitors. Amsterdam, North Holland, 1975, pp 497-508.Google Scholar
  23. 23.
    Borgers M, De Nollin S, Thone F, Van Belle H: Cytochemical localization of NADH oxidase in Candida albicans. J Histochem Cytochem 25:193–199, 1977.PubMedCrossRefGoogle Scholar
  24. 24.
    Borgers M, Vanden Bossche H, De Brabander M, Van Cutsem J: Promotion of pseudomycelium formation of Candida albicans in culture: A morphological study of the effects of miconazole and ketoconazole. Postgrad Med J 55: 687–691, 1979.PubMedCrossRefGoogle Scholar
  25. 25.
    Borgers M, Levine HB, Cobb JM: Ultrastructure of Coccidioides immitis after exposure to the imidazole antifungals miconazole and ketoconazole. Sabouraudia 9:27–3S, 1981.CrossRefGoogle Scholar
  26. 26.
    Borgers M, Vanden Bossche H, De Brabander M: The mechanism of action of the new antimycotic ketoconazole. Am J Med 74:2–7, 1983.PubMedCrossRefGoogle Scholar
  27. 27.
    Bozzola JJ, Mehta RJ, Nisbet LJ, Valenta JR: The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicans . Can J Microbiol 30:857–863, 1984.PubMedCrossRefGoogle Scholar
  28. 28.
    Breslau A, Hensley T, Erickson J : Electron microscopy of cultured spherules of Coccidioides immitis. J Biophys Biochem Cytol 9:627–637, 1961.PubMedCrossRefGoogle Scholar
  29. 29.
    Cassone A, Kerridge D, Gale EF: Ultrastructural changes in the cell wall of Candida albicans following cessation of growth and their possible relationship to the development of polyene resistance. J Gen Microbiol 110:339–349, 1979.PubMedGoogle Scholar
  30. 30.
    Cassone A, Mason RE, Kerridge D: Lysis of growing yeast-form cells of Candida albicans and by echinocandin: A cytological study. Sabouraudia 19:97–110, 1981.PubMedCrossRefGoogle Scholar
  31. 31.
    Catterall MD, Ward ME, Jacobs P: A reappraisal of the role of Pityrosporum orbiculare in pityriasis versicolor and the significance of extracellular lipase. J Invest Dermatol 71:398–401, 1978.PubMedCrossRefGoogle Scholar
  32. 32.
    Costa AL : In vitro antimycotic activity of fenticonazole. Mykosen 25:47–52, 1981.Google Scholar
  33. 33.
    Costa AL, Valenti A, Veronese M: Study of the morphofunctional alterations produced by fenticonazole on strains of Candida albicans, using the scanning electron microscope (S.E.M.). Mykosen 27:29–35, 1983.Google Scholar
  34. 34.
    Danilenko II, Stepanyuk W: Ultrastructure, composition of neutral lipids and their fatty acids of Candida tropicalis strain D-2 mutants resistant to the polyene antibiotic nystatin. BBA 691:201–210, 1982.PubMedCrossRefGoogle Scholar
  35. 35.
    D’Arcy PF, Scott EM: Antifungal agents, E Jucker : Progress in Drug Research. Basel, Birkhauser Verlag, 1978, pp 93–147.Google Scholar
  36. 36.
    De Brabander M, Aerts F, Van Cutsem J, Vanden Bossche H, Borgers M: The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans . Sabouraudia 18:197–210, 1980.PubMedCrossRefGoogle Scholar
  37. 37.
    Degreef H, Van De Kerckhove M, Gevers D, Van Cutsem J, Vanden Bossche H, Borgers M: Ketoconazole (R 41400) in the treatment of dermatophyte infections. IntJDermatol 20:662–669, 1981.PubMedCrossRefGoogle Scholar
  38. 38.
    De Nollin S, Borgers M: The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia 12:341–351, 1974.PubMedCrossRefGoogle Scholar
  39. 39.
    De Nollin S, Borgers M: Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob Agents Chemother 7:704–711, 1975.PubMedGoogle Scholar
  40. 40.
    De Nollin S, Borgers M: An ultrastructural and cytochemical study of Candida albicans after in vitro treatment with imidazoles. Mykosen 19:317–328, 1976.PubMedGoogle Scholar
  41. 41.
    De Nollin S, Thone F, Borgers M: Enzyme cytochemistry of Candida albicans . J Histochem Cytochem 23:758–765, 1975.PubMedCrossRefGoogle Scholar
  42. 42.
    De Nollin S, Van Belle H, Goossens F, Thone F, Borgers M: Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother 11:500–513, 1977.PubMedGoogle Scholar
  43. 43.
    De Nollin S, Jacob W, Garrevoet T, Van Daele A, Dockx P: Influence of econazole and 5-fluorocytosine on the ultrastructure ofAspergillusfumigatus and the cytochemical localization of calcium ions as measured by laser microprobe mass analysis. Sabouraudia 21:287–302, 1983.PubMedCrossRefGoogle Scholar
  44. 44.
    De Nollin S, Jacob W, Dockx P: Laser microprobe mass analysis (LAMMA) of cytochemically localized calcium on Aspergillus fumigatus after exposure to ketoconazole. Abstr 4133 , Hlth Int Congress on Cell Biology, Tokyo, p. 464,1984.Google Scholar
  45. 45.
    Djaczenko W, Cassone A : Visualization of new ultrastructural components in the cell wall of Candida albicans with fixatives containing Tapo. J Cell Biol 52:186–192, 1971.CrossRefGoogle Scholar
  46. 46.
    Dockx P : In vitro microscopic study of fungus cells treated with econazole. Mykosen 24:218–223, 1980.Google Scholar
  47. 47.
    Evans G, White NH: Effect of the antibiotics radicicolin and griseofulvin on the fine structure of fungi. J Exp Bot 18:465–470, 1967.CrossRefGoogle Scholar
  48. 48.
    Foury F, Goffeau A: Stimulation of active uptake of nucleosides and amino acids by cyclic adenosine 3’: 5’-monophosphate in the yeast Schizosaccharomyces pombe. J Biol Chem 250:2354–2362, 1975.PubMedGoogle Scholar
  49. 49.
    Fromtling RA, Yu HP, Shadomy S: In vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n7133 and Bay L 9139. Sabouraudia 21:179–184, 1983.PubMedCrossRefGoogle Scholar
  50. 50.
    Gale GR : Cytology of Candida albicans as influenced by drugs acting on the cytoplasmic membrane. J Bacteriol 86:151–157, 1963.PubMedGoogle Scholar
  51. 51.
    Gale EF, Cundliffe E, Reynolds PE, Richmond MH, Waring MJ: The Molecular Basis of Antibiotic Action. London, Wiley & Sons, 1982, pp 201–219.Google Scholar
  52. 52.
    Godefroi EF, Heeres J, Van Cutsem J, Janssen PAJ: The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem 12:784–791, 1969.PubMedCrossRefGoogle Scholar
  53. 53.
    Gunther TH, Kattner W, Mesher HJ: Uber das Verhalten und die Lokalisation der sauren Phosphatase von Hefezellen bei Repression und Derepression. Exp Cell Res 45:133–138, 1966.CrossRefGoogle Scholar
  54. 54.
    Hamilton-Miller JMT : Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev 37:166–196, 1973.Google Scholar
  55. 55.
    Heel RC, Brogden RN, Speight TM, Avery GS : Econazole: A review of its antifungal activity and therapeutic efficacy. Drugs 16:177–201, 1978.PubMedCrossRefGoogle Scholar
  56. 56.
    Heeres J, Backx LJJ, Mostmans JH, Van Cutsem J: The synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem 22:1003–1007, 1979.PubMedCrossRefGoogle Scholar
  57. 57.
    Heeres J, Hendrickx R, Van Cutsem J: Antimycotic azoles. Part 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem 26: 611–613,1983.PubMedCrossRefGoogle Scholar
  58. 58.
    Heeres J. Backx LJJ, Van Cutsem J: Antimycotic azoles. Part 7. Synthesis and antimycotic properties of a series of novel triazol-3-ones. J Med Chem 27: 894–900, 1984.PubMedCrossRefGoogle Scholar
  59. 59.
    Hino H, Takizawa K, Asboe-Hansen G: Ultrastructure of Cryptococcus neoformans . Acta Dermatovener 62:113–117, 1982.Google Scholar
  60. 60.
    Humphrey MJ, Jevons S, Tarbit MH: Pharmacokinetic evaluation of UK-49858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother 28:648–653, 1985.PubMedGoogle Scholar
  61. 61.
    Ito S : Fine structure of Cryptococcus neoformans. An electron microscopic study. Jpn J Dermatol 76:65, 1966.Google Scholar
  62. 62.
    Iwata K, Kanda Y, Yamaguchi H, Osumi M: Electron microscopic studies on the mechanisms of action of clotrimazole on Candida albicans . Sabouraudia 11:205–209, 1973.PubMedCrossRefGoogle Scholar
  63. 63.
    Jevans S, Gymer GE, Brammer KW, Cox DA, Lemming MRG: Antifungal activity of tioconazole (UK-20.349), a new imidazole derivative. Antimicrob Agents Chemother 15:597–602, 1979.Google Scholar
  64. 64.
    Karaoui R, Bou-Resli M, Al-Zaid NS, Mousa A: Tinea versicolbr: Ultrastructural studies on hypopigmented and hyperpigmented skin. Dermatologica 162: 69–85, 1981.PubMedCrossRefGoogle Scholar
  65. 65.
    Kanazawa T : Antimycotic action of A diamidine compound, 1, 4-bis-(M,M’-amidinophenoxymethyl)-cyclohexane dilactate on Candida albicans. Acta Med Okayama 35:327–341, 1981.PubMedGoogle Scholar
  66. 66.
    Keddie FM : Electron microscopy of Malassezia furfur in tinea versicolor. Sabouraudia 5:134–137, 1966.PubMedCrossRefGoogle Scholar
  67. 67.
    Kerridge D, Whelan WL: The polyene macrolide antibiotics and 5-fluorocytosine: Molecular actions and interactions, API Trinci, JE Ryley : Mode of Action of Antifungal Agents. London, Cambridge University Press, 1984, pp 343–375.Google Scholar
  68. 68.
    Kerridge D, Koh TY, Johnson AM: The interaction of amphotericin B methyl ester with protoplasm of Candida albicans. J Gen Microbiol 96:117–123, 1976.PubMedGoogle Scholar
  69. 69.
    Kessler HJ : Mikrobiologische Untersuchungen mit Isoconazolnitrat, einem Breitspektrum-Antimykotikum aus der Gruppe der Imidazol-Derivate. Arzneim Forsch 29:1344–1351, 1979.Google Scholar
  70. 70.
    Kitajima Y, Sekiya T, Nozawa Y: Freeze fracture ultrastructural alterations induced by filipin, pimaricin, nystatin and amphotericin B in the plasma membrane of Epidermophyton, Saccharomyces and red blood cells. A proposal of models for polyene ergosterol complex-induced membrane lesions. BBA 445: 452–465, 1976.CrossRefGoogle Scholar
  71. 71.
    Malawista SE : Microtubules and the movement of melanin granules in frog dermal melanocytes. Ann NY Acad Sci 253:702–710, 1975.PubMedCrossRefGoogle Scholar
  72. 72.
    Manna VK, Pearse AD, Marks R: T he effect of Povidone-Iodine paint on fungal infection. J Int Med Res 12:121–123, 1984.PubMedGoogle Scholar
  73. 73.
    Marichal P, Gorrens J, Vanden Bossche H: The action of itraconazole and ketoconazole on growth and sterol synthesis in Aspergillus fumigatus and Aspergillus niger. Sabouraudia : J Med Vet My col 22:13–21, 1984.Google Scholar
  74. 74.
    Masperi P, Dalfolio G, Calefano A, Vannini GL: Autophagic vacuole development in Trichophyton mentagrophytes exposed in vitro to miconazole. Sabouraudia : J Med Vet My col 22:27–35, 1984.CrossRefGoogle Scholar
  75. 75.
    Matille PH, Moor H, Robinow C: Biology of yeast, A Rose, J Harrison : Yeast Cytology, Vol. 1. London and New York, Academic Press, 1969, pp 219–302.Google Scholar
  76. 76.
    Mazabrey D, Nadal J, Seguela JP, Linas MD: Scanning and transmission electron microscopy: Study of effects of econazole on Microsporum canis . Mycopathologia 91:151–157, 1985.PubMedCrossRefGoogle Scholar
  77. 77.
    MedoffG, Kobayashi GA: The polyenes, DEC Speller : Antifungal Chemotherapy. London, Wiley & Sons, 1980, pp 3–33.Google Scholar
  78. 78.
    Meingassner JG, Sleytr UB: The effects of naftifine on the ultrastructure of Candida parapsilosis: A freeze fracture study. Sabouraudia 20:199–207, 1982.PubMedCrossRefGoogle Scholar
  79. 79.
    Meingassner JG, Sleytr U, Petranyi G: Morphological changes induced by naftifine, a new antifungal agent, in Trichophyton mentagrophytes . J Invest Dermatol 77:444–451, 1981.PubMedCrossRefGoogle Scholar
  80. 80.
    Meingassner JG, Sleytr UB, Petranyi G: SF 86-327: Effects on the ultrastructure of Trichophyton mentagrophytes in vitro. 13th Int Congress of Chemotherapy, Vienna PS 4.8/4.7, 1983.Google Scholar
  81. 81.
    Meingassner JG, Miiller M. Sleytr UB: SF-86-327: Effects on the ultrastructure of Candida albicans in vitro. 13th Int Congress of Chemotherapy, Vienna, 1983, PS 4.8/4-8.Google Scholar
  82. 82.
    Mixich G, Thiele K: Ein Beitrag zur stereospezifischen Synthese von antimykotisch wirksamen Imidazolyloximathern. Oxiconazole-nitrat (Sgd 301-76), ein neues Breitbandantimykotikum. Arzneim Forsch 29:1510–1513, 1979.Google Scholar
  83. 83.
    Montes LF : Systemic abnormalities and the intracellular site of infections of the stratum corneum. JAMA 213:1469–1472, 1970.PubMedCrossRefGoogle Scholar
  84. 84.
    Montes LF, Patrick TA, Martin SA, Smith M: Ultrastructure of blastospores of Candida albicans after permanganate fixation. Invest Dermatol 45:227, 1965.Google Scholar
  85. 85.
    Moor H, Miihlethaler K: Fine structure in frozen-etched yeast cells. J Cell Biol 17:609–628, 1963.PubMedCrossRefGoogle Scholar
  86. 86.
    Negroni de Bonvehi MB, Borgers M, Negroni R: Ultrastructural changes produced by ketoconazole in the yeast-like phase of Paracoccidioides brasiliensis and Histoplasma capsulatum . Mycopathologia 74:113–118, 1981.PubMedCrossRefGoogle Scholar
  87. 87.
    Negroni de Bonvehi MB, Van de Ven M, Borgers M, Negroni R: Ultrastructural changes produced by ketoconazole in Cryptococcus neoformans and Sporothrix schenckii . Clin Res Rev 3:5–11, 1983.Google Scholar
  88. 88.
    Norberg B : Cytoplasmic micro tubules and radial segmented nuclei (Rieder cells). Effects of osmolality, ionic strength, pH, penetrating non-electrolytes, griseofulvin and a podophyllin derivative. Scand J Haematol 1:445–454, 1970.Google Scholar
  89. 89.
    Nozawa Y, Kitajima Y, Sekiya T, Ito Y: Ultrastructural alterations induced by amphotericin B in the plasma membrane of Epidermophyton floccosum as revealed by freeze-etch electron microscopy. BBA 367:32–38, 1974.PubMedCrossRefGoogle Scholar
  90. 90.
    Osumi M, Yamada N, Okada J, Yamaguchi H, Hiratani T, Plempel: The effect of bifonazole on the structure of Triehophyton. Arzneim Forsch Drug Res 33: 1484–1491, 1983.Google Scholar
  91. 91.
    Osumi M, Yamada N, Yamada Y, Yamaguchi H: The effect of bifonazole on the structure of Trichophyton mentagrophytes. Dermatologica 169:19–32, 1984.PubMedCrossRefGoogle Scholar
  92. 92.
    Palacios J, Serrano R: Proton permeability induced by polyene antibiotics. A plausible mechanism for their inhibition of maltose fermentation in yeast. FEBS Letters 91:198–201, 1978.PubMedCrossRefGoogle Scholar
  93. 93.
    Pena A : Studies on the mechanism of K+ transport in yeast. Arch Biochem Biophys 167:397–419, 1975.PubMedCrossRefGoogle Scholar
  94. 94.
    Pesti M, Novak EK, Ferenczy L, Svoboda A: Freeze fracture electron microscopical investigation of Candida albicans cells sensitive and resistant to nystatin. Sabouraudia 19:17–26, 1981.PubMedCrossRefGoogle Scholar
  95. 95.
    Pesti M, Becher D, Bartsch G: The effect of miconazole on ergosterolless mutant of Candida albicans . Acta Microbiol Hung 30:25–29, 1983.PubMedGoogle Scholar
  96. 96.
    Petrou MA, Rogers TR: A comparison of the activity of mepartricin and amphotericin B against yeasts. J Antimicrob Chemother 16:169–178, 1985.PubMedCrossRefGoogle Scholar
  97. 97.
    Plempel M, Bartmann K, Biichel KH, Regel E: Experimented Befunde uber ein neues oral wirksames Antimykotikum mit breiten Wirkungsspecktrum. Deutsche Med Wochenschr 94:1356–1364, 1969.CrossRefGoogle Scholar
  98. 98.
    Plempel M, Regel E, Biichel KH: Antimycotic efficacy of bifonazole in vitro and in vivo. Arzneim Forsch 33:517–524, 1982.Google Scholar
  99. 99.
    Polak A, Grenson M: Evidence for a common transport system for cytosine, adenine and hypoxanthine in Saccharomyces cerevisiae and Candida albicans . Eur J Biochem 32:276–282, 1973.PubMedCrossRefGoogle Scholar
  100. 100.
    Preusser HJ : Die Wirkung von Econazol auf die Feinstruktur der Zellen von Trichophyton rubrum. Mykosen 18:453–465, 1975.PubMedGoogle Scholar
  101. 101.
    Preusser HJ : Effects of in vitro treatment with econazole on the ultrastructure of Candida albicans. Mykosen 19:304–316, 1976.PubMedGoogle Scholar
  102. 102.
    Preusser HJ: Trichophyton rubrumlCandida albicans. Stuttgart, Gustaf Fischer Verlag, 1982, pp 1–109.Google Scholar
  103. 103.
    Raab WPE: The Treatment of Mycoses With Imidazole Derivatives. Berlin, Springer-Verlag, 1980.Google Scholar
  104. 104.
    Readio JD, Bittman R: Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols. BBA 685:219–224, 1982.PubMedCrossRefGoogle Scholar
  105. 105.
    Scheklakow ND, Delektorski WW, Golodova OA: Veranderungen der Ultrastruktur von Candida albicans unter der Einwirkung von Polyenantibiotika. Mykosen 24:140–152, 1981.PubMedGoogle Scholar
  106. 106.
    Scherwitz C : Ultrastrukturelle Untersuchungen zur Wirkung von Econazolnitrat auf die Candida albicans Mykose der menschlichen Haut. Mykosen 24: 244–247, 1980.Google Scholar
  107. 107.
    Scholer HJ: Flucytosine, DCE Speller : Antifungal Chemotherapy. London, Wiley & Sons, 1980, pp 35–106.Google Scholar
  108. 108.
    Scott EM, Gorman SP, McGrath SJ: Inhibition of hyphal development in Trichophyton mentagrophytes arthroconidia by ketoconazole and miconazole. JAntimicrob Chemother 15:405–415, 1985.CrossRefGoogle Scholar
  109. 109.
    Sekiya T, Yano K, Nozawa Y: Effects of amphotericin B and its methyl ester on plasma membranes of Candida albicans and erythrocytes as examined by freezefracture electron microscopy. Sabouraudia 20:303–311, 1982.PubMedCrossRefGoogle Scholar
  110. 110.
    Shadomy S : In vitro studies with 5-fluorocytosine. Appl Microbiol 17:871–877, 1969.PubMedGoogle Scholar
  111. 111.
    Sobel JD: Pathogenesis of vaginal candidosis, BW Eliot : Oral Therapy in Vaginal Candidosis. Oxford, Medicine Publishing Foundation, 1984, pp 1–13.Google Scholar
  112. 112.
    Sun SH, Huppert M: A cytological study of morphogenesis in Coccidioides immitis . Sabouraudia 14:184–198, 1976.CrossRefGoogle Scholar
  113. 113.
    Sun SH, Sekhon SS, Huppert M: Electron microscopic studies of saprobic and parasitic forms of Coccidioides immitis . Sabouraudia 17:265–273, 1979.PubMedCrossRefGoogle Scholar
  114. 114.
    Tanenbaum L, Anderson C, Chaplin M, Jones R, Matthews T, Walker K: Sulconazole nitrate 1% cream: Preclinical and clinical profile. Abstr llth Int Congr Chemother. No. 148, Boston, 1979.Google Scholar
  115. 115.
    Thienpont D, Van Cutsem J, Borgers M: Ketoconazole in experimental candidosis. Rev Infect Dis 2:570–576, 1980.PubMedCrossRefGoogle Scholar
  116. 116.
    Tolman EL, Isaacson DM, Rosenthale ME, McGuire JL, Van Cutsem J, Borgers M, Vanden Bossche H: Anticandidal activities of terconazole, a broad-spectrum antimycotic. Antimicrob Agents Chemother 29:986–991, 1986.PubMedGoogle Scholar
  117. 117.
    Van Cutsem J, Van Gerven F, Van de Ven MA, Borgers M, Janssen PAJ: Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother 26:527–534, 1984.PubMedGoogle Scholar
  118. 118.
    Vanden Bossche H : Biochemical targets for antifungal azole-derivative. Hypothesis of the mode of action. Curr Topics Med My col 1:313–351, 1985.Google Scholar
  119. 119.
    Vanden Bossche H, Willemsens G, Cools W, Marichal P, Lauwers W: Hypothesis on the molecular basis for the antifungal activation of N-substituted imidazoles and triazoles. Biochem Soc Trans 11:665–667, 1983.PubMedGoogle Scholar
  120. 120.
    Vanden Bossche H, Lauwers, W, Willemsens G, Marichal P, Cornelissen F, Cools W: Molecular basis for antimycotic and antibacterial activity of Nsubstituted imidazoles and triazoles: The inhibition of isoprenoid biosynthesis. Pest Sci 15:188–198, 1984.CrossRefGoogle Scholar
  121. 121.
    Vannini GL, Mares D, Giori P, Bonora A: Antifungal properties of some pyrazolyl-sulfides. Mycopathologia 74:l–l4, 1981.CrossRefGoogle Scholar
  122. 122.
    Walker KAM, Braemer AC, Hitt S, Jones RE, Matthews TR: l-[4-(4-chlorophenyl)-2-(2, 6-dichlorophenylthio)-n-butyl]-lH-imidazole nitrate, a new potent antifungal agent. J Med Chem 21:840–843, 1978.PubMedCrossRefGoogle Scholar
  123. 123.
    Weber K, Wehland J, Herzog W: Griseofulvin interacts with microtubules both in vivo and in vitro. J Mol Biol 102:817–830, 1976.PubMedCrossRefGoogle Scholar
  124. 124.
    Wiemken A: Eigenschaften der Hefevacuole (Thesis). Zürich, Eidgenössischen Technischen Hochschule 1969.Google Scholar
  125. 125.
    Wooley DW: Some biological effects produced by benzimidazole and their reversal by purines. J Biol Chem 152:225–232, 1944.Google Scholar
  126. 126.
    Yamaguchi H, Iwata K, Nagano M, Osumi M: Ultrastructure of Saccharomyces cerevisaae treated with econazole. J Electron Microsc 30:305–314, 1981.Google Scholar
  127. 127.
    Yamaguchi H, Hiratani R, Plempel M: In vitro studies of a new oral azole antimycotic, BAY n7133. J Antimicrob Chem 11: 135–149, 1983CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • Marcel Borgers

There are no affiliations available

Personalised recommendations